Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: New insights

by MacDougall, I.C., Roger, S.D., De Francisco, A., Goldsmith, D.J.A., Schellekens, H., Ebbers, H., Jelkmann, W., London, G., Casadevall, N., Hörl, W.H., Kemeny, D.M., Pollock, C.
Published 2016